Any feedback?
Literature summary for 3.4.21.59 extracted from
- Tissue engineered human prostate microtissues reveal key role of mast cell-derived tryptase in potentiating cancer-associated fibroblast (CAF)-induced morphometric transition in vitro (2019), Biomaterials, 197, 72-85 .
Inhibitors
| Inhibitors | Comment | Organism | Structure |
|---|---|---|---|
| nafamostat mesylate | - |
Homo sapiens |  |
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Homo sapiens | - |
- |
- |
Source Tissue
| Source Tissue | Comment | Organism | Textmining |
|---|---|---|---|
| mast cell | - |
Homo sapiens | - |
Synonyms
| Synonyms | Comment | Organism |
|---|---|---|
| mast cell-derived tryptase | - |
Homo sapiens |
General Information
| General Information | Comment | Organism |
|---|---|---|
| physiological function | mast cell-derived tryptase potentiates cancer-associated fibroblast-induced morphology changes of prostate epithelia indirectly via the tumour microenvironment | Homo sapiens |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
